The Med19 has been reported to promote tumor growth and/or metastasis in ovarian cancer, gastric cancer, pancreatic cancer, osteosarcoma, and liver cancer [5–7, 17–18]. This evidence concerns the gene MED19 and familial pancreatic carcinoma.